Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Veronika Lenz"'
Autor:
Sina Schwarzkopf, Adalbert Krawczyk, Dietmar Knop, Hannes Klump, Andreas Heinold, Falko M. Heinemann, Laura Thümmler, Christian Temme, Marianne Breyer, Oliver Witzke, Ulf Dittmer, Veronika Lenz, Peter A. Horn, Monika Lindemann
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 1, Pp 122-129 (2021)
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/
Externí odkaz:
https://doaj.org/article/2c9c32d7cac243e7b5a17ab7e449c7a2
Autor:
Laura Thümmler, Monika Lindemann, Peter A. Horn, Veronika Lenz, Margarethe Konik, Anja Gäckler, Kristina Boss, Fotis Theodoropoulos, Vasiliki Besa, Christian Taube, Thorsten Brenner, Oliver Witzke, Adalbert Krawczyk, Hana Rohn
Publikováno v:
Viruses, Vol 15, Iss 1, p 119 (2022)
Vulnerable patients such as immunosuppressed or elderly patients are at high risk for a severe course of COVID-19 upon SARS-CoV-2 infection. Immunotherapy with SARS-CoV-2 specific monoclonal antibodies (mAb) or convalescent plasma represents a consid
Externí odkaz:
https://doaj.org/article/c61dcd6137864c6cbac2605228f22a20
Publikováno v:
ZDfm – Zeitschrift für Diversitätsforschung und -management. 6:244-248
Bibliographie: Baumgart, Cornelia/Lenz, Veronika/Horn, Peter A.: Blutgruppendiversitat – ein Thema nur fur die Medizin?, ZDfm – Zeitschrift fur Diversitatsforschung und -management, 2-2021, S. 244-248. https://doi.org/10.3224/zdfm.v6i2.16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acf80bf8e3fdec0cea5b92e9e3783220
https://doi.org/10.3224/zdfm.v6i2.16
https://doi.org/10.3224/zdfm.v6i2.16
Autor:
Maryam Said, Thiemo Florin Dinger, Meltem Gümüs, Laurèl Rauschenbach, Mehdi Chihi, Jan Rodemerk, Veronika Lenz, Marvin Darkwah Oppong, Anne-Kathrin Uerschels, Philipp Dammann, Karsten Henning Wrede, Ulrich Sure, Ramazan Jabbarli
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 21; Pages: 6258
Objective: Previous reports indicate a negative impact of anemia on the outcome of an aneurysmal subarachnoid hemorrhage (SAH). We aimed to identify the outcome-relevant severity of post-SAH anemia. Methods: SAH cases treated at our institution betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b8a62f740806e95ebe54793dbc453c
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00077717/jcm_2022_11-06258.pdf
https://duepublico2.uni-due.de/servlets/MCRFileNodeServlet/duepublico_derivate_00077717/jcm_2022_11-06258.pdf
Autor:
Cornelius Knabbe, Hannes Klump, Michael Koldehoff, Frank Herbstreit, Adalbert Krawczyk, Ulf Dittmer, Peter A. Horn, Dietmar Knop, Andreas Heinold, Veronika Lenz, Sebastian Dolff, Mira Alt, Oliver Witzke, Nina K. Steckel, Leonie Schipper, Thorsten Brenner, Gabriele Hutschenreuter, Ulrich Wilhelm Aufderhorst, Monika Lindemann, Johannes C. Fischer, Falko M. Heinemann, Lara Meller, Sina Schwarzkopf
Publikováno v:
Transfusion
Background Infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may be life‐threatening, and specific antiviral drugs are currently not available. However, first studies indicated that convalescent plasma treatment might
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96659602f6a2f0d4334dcd5c50826923
http://europepmc.org/articles/PMC8251157
http://europepmc.org/articles/PMC8251157
Autor:
Andreas Heinold, Laura Thümmler, Oliver Witzke, Ulf Dittmer, Peter A. Horn, Monika Lindemann, Adalbert Krawczyk, Dietmar Knop, Hannes Klump, Falko M. Heinemann, Sina Schwarzkopf, Marianne Breyer, Christian Temme, Veronika Lenz
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 1, Pp 122-129 (2021)
Emerging Infectious Diseases
Emerging Infectious Diseases
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d2c09096cc1e11cb8c23436b9a48aa
https://doi.org/10.3201/eid2701.203772
https://doi.org/10.3201/eid2701.203772
Autor:
Adalbert Krawczyk, Hannes Klump, Marianne Breyer, Veronika Lenz, Laura Thümmler, Lukas van de Sand, Peter A. Horn, Sebastian Dolff, Monika Lindemann, Leonie Schipper, Oliver Witzke, Margarethe Konik, Dietmar Knop, Maximillian Platte, Hana Rohn, Christian Temme, Sina Schwarzkopf, Ulf Dittmer, Maren Bormann
Publikováno v:
Journal of Medical Virology
When patients with chronic kidney disease are infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) they can face two specific problems: virus‐specific immune responses may be impaired and remdesivir, an antiviral drug desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b41e46a5278b210c9b50b749d1f671
https://pubmed.ncbi.nlm.nih.gov/33527424
https://pubmed.ncbi.nlm.nih.gov/33527424
Autor:
Dietmar Knop, Margarethe Konik, Lukas van de Sand, Ulf Dittmer, Hana Rohn, Christian Temme, Laura Thümmler, Marianne Breyer, Sebastian Dolff, Leonie Schipper, Peter A. Horn, Maren Bormann, Sina Schwarzkopf, Veronika Lenz, Monika Lindemann, Oliver Witzke, Maximillian Platte, Adalbert Krawczyk, Hannes Klump
BackgroundWhen patients with chronic kidney disease are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) they can face two specific problems: Virus-specific immune responses may be impaired and remdesivir, an antiviral drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5bc4cfc290364b493514ee1a91d4cae
https://doi.org/10.1101/2020.12.09.20239673
https://doi.org/10.1101/2020.12.09.20239673
Autor:
Colin Vance, Alexander Carpinteiro, Frank Herbstreit, Ferras Alashkar, Tobias Liebregts, Veronika Lenz, Alexander Röth, Carmen Aramayo-Singelmann, Michael Koldehoff, Julia Baum, Dirk Reinhardt, Ulrich Dührsen, Asterios Tzalavras, Erich Gulbins, Dietrich W. Beelen
Acute chest syndrome (ACS) in adult patients with sickle cell disease represents a leading cause of death. It is characterized by a new density on chest X-ray accompanied by fever and/or respiratory symptoms. Currently, 49 adult patients with sickle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce63a9eb59a8e1a76e033f49670886da
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85083581730
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85083581730
Publikováno v:
Transfusionsmedizin - Immunhämatologie, Hämotherapie, Immungenetik, Zelltherapie. 7:233-237
ZusammenfassungBei der Lebendnierenspende hat man die Chance, das immunologische Risiko vor Transplantation sehr detailliert zu testen. Neben der Bestimmung der humanen Leukozytenantigene (HLA) ist die Suche nach HLA-Antikörpern und die Verträglich
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6cbc32d168b9cb6ac51f5e7a1028bd
https://doi.org/10.1055/s-0043-113802
https://doi.org/10.1055/s-0043-113802